Cormorant Asset Management, LP Mirati Therapeutics, Inc. Transaction History

Cormorant Asset Management, LP

$1.27 Billion
Q4 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$41.27 - $98.62 $7.22 Million - $17.3 Million	-175,000 Reduced 30.43%	400,000 $18.1 Million
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $16.4 Million - $23.8 Million	275,000 Added 91.67%	575,000 $40.2 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $9.79 Million - $22.2 Million	250,000 Added 500.0%	300,000 $20.1 Million
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $1.9 Million - $3.77 Million	-25,000 Reduced 33.33%	50,000 $4.11 Million
Q4 2021 Feb 14, 2022	SELL	$132.01 - $190.29 $5.94 Million - $8.56 Million	-45,000 Reduced 37.5%	75,000 $11 Million
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $7.27 Million - $9.76 Million	-55,000 Reduced 31.43%	120,000 $21.2 Million
Q2 2021 Aug 16, 2021	SELL	$144.0 - $179.73 $14.4 Million - $18 Million	-100,000 Reduced 36.36%	175,000 $28.3 Million
Q1 2021 May 17, 2021	SELL	$158.92 - $221.61 $7.95 Million - $11.1 Million	-50,000 Reduced 15.38%	275,000 $47.1 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $8.1 Million - $12 Million	50,000 Added 18.18%	325,000 $71.4 Million
Q3 2020 Nov 16, 2020	SELL	$113.26 - $167.27 $25.5 Million - $37.6 Million	-225,000 Reduced 45.0%	275,000 $45.7 Million
Q2 2020 Aug 14, 2020	SELL	$72.01 - $120.39 $25.2 Million - $42.1 Million	-350,000 Reduced 41.18%	500,000 $57.1 Million
Q1 2020 May 15, 2020	SELL	$69.78 - $116.21 $30.2 Million - $50.2 Million	-432,392 Reduced 33.72%	850,000 $65.3 Million
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $22.5 Million - $40.9 Million	-317,608 Reduced 19.85%	1,282,392 $165 Million
Q3 2019 Nov 14, 2019	BUY	$77.91 - $109.6 $39 Million - $54.8 Million	500,000 Added 45.45%	1,600,000 $125 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $1.49 Million - $2.62 Million	25,000 Added 2.33%	1,100,000 $113 Million
Q1 2019 May 15, 2019	SELL	$43.65 - $78.95 $29.5 Million - $53.4 Million	-676,699 Reduced 38.63%	1,075,000 $78.8 Million
Q4 2018 Feb 14, 2019	SELL	$32.0 - $47.43 $1.87 Million - $2.77 Million	-58,301 Reduced 3.22%	1,751,699 $74.3 Million
Q3 2018 Nov 14, 2018	SELL	$47.1 - $62.7 $5.1 Million - $6.79 Million	-108,350 Reduced 5.65%	1,810,000 $85.3 Million
Q1 2018 May 15, 2018	BUY	$17.2 - $34.95 $11.8 Million - $24 Million	686,828 Added 55.77%	1,918,350 $58.9 Million
Q4 2017 Feb 14, 2018	BUY	$12.65 - $19.0 $2.93 Million - $4.4 Million	231,522 Added 23.15%	1,231,522 $22.5 Million
Q3 2017 Nov 14, 2017	BUY	$4.7 - $11.7 $4.7 Million - $11.7 Million	1,000,000	1,000,000 $11.7 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Account